log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Autor Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Vydáno 2010

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

Autor Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Vydáno 2012

Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B(100) in patients with T2DM

Autor Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Vydáno 2013

Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids

Autor Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Vydáno 2014

The mixed benefit of low lipoprotein(a) in type 2 diabetes

Autor Hermans, Michel P., Ahn, Sylvie A., Rousseau, Michel F.
Vydáno v Lipids Health Dis (2017)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B(100 )measurement in diabetes: Discriminant Ratio and unbiased equivalence

Autor Hermans, Michel P, Sacks, Frank M, Ahn, Sylvie A, Rousseau, Michel F
Vydáno 2011

Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies

Autor Hermans, Michel P., Bouenizabila, Evariste, Amoussou-guenou, Daniel K., Ahn, Sylvie A., Rousseau, Michel F.
Vydáno v Cardiovasc Diabetol (2015)

1,25-Dihydroxyvitamin D to PTH(1–84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

Autor Gruson, Damien, Ferracin, Benjamin, Ahn, Sylvie A., Zierold, Claudia, Blocki, Frank, Hawkins, Douglas M., Bonelli, Fabrizio, Rousseau, Michel F.
Vydáno v PLoS One (2015)